Dr. Grant does research into the neurocognitive and neurobehavioral outcomes of individuals living with congenital and acquired medical conditions.

Representative Sample of Publications (*peer reviewed journals)

*"Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria"
Bilder DA, Arnold GL, Dimmock D, Grant ML, Janzen D, Longo N, Nguyen-Driver M, Jurecki E, Merilainen M, Amato G and Waisbren S
The American Journal of Medical Genetics Part A, 1-11. https://doi.org/10.1002/ajmg.a.62574 (2021)

"Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU"
Christ SE, Clocksin HE, Burton BK, Grant ML, Waisbren S, Paulin M, Bilder DA, White DA and Saville C
Neuropsychology, 34(4), 456. PMID:32202818. DOI:10.1037/neu0000625 (2020)

*"Neuropsychiatric Comorbidities in Adults with Phenylketonuria: A Retrospective Cohort Study"
Bilder DA, Kobori JA, Cohen-Pfeffer JL, Johnson EM, Jurecki ER and Grant ML
Molecular Genetics and Metabolism, Volume 121, Issue 1, Pages 1-8 (May 2017)

*"Exposure to violence and virologic and immunological outcomes among youth with perinatal HIV in the Pediatric HIV/AIDS Cohort Study"
Kacanek D, Malee K , Mellins CA, Tassiopoulos K, Smith R, Grant M, Lee S, Siddiqui DQ, Puga A, for the Pediatric HIV/AIDS Cohort Study
Journal of Adolescent Health, Volume 59, Issue 1, Pages 30–37 (July 2016)

*"Newborn Screening 50 Years Later: Access Issues Faced by Adults with PKU"
Berry SA, Brown C, Grant M, Greene C, Jurecki E, Koch J, Moseley K, Suter R, van Calcar S, Wiles J, Cederbaum S.
Genetics in Medicine, 15, 591-599 (2013)

*"A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria"
Burton B, Grant M, Feigenbaum A, Singh R, Hendren R, Siriwardena K, Phillips III J, Sanchez-Valle A, Waisbren S, Gillis J, Prasad S, Merilainen M, Lang W, Zhang C, Yuj S, and Stahl S
Molecular Genetics and Metabolism, 114 (3), 415-424 (2014)

*"Severity of Obstructive Sleep Apnea in Children with Sickle Cell Disease"
Kaleyias J, Mostofi N, Grant ML, Coleman C, Luck L, Dampier C and Kothare S
Journal Of Pediatric Hematology And Oncology, 30 (9); 659-665 (2008)

*"Chronic sorrow and coping in families of children with epilepsy"
Hobdell E, Grant ML, Valencia I, Mare J, Legido A and Khurana D
Journal of Neuroscience Nursing, 39 (2): 76-82 (2007)
Article eligible for continuing education credits for nurses

Representative Sample: Invited Presentations

"Expanding Evaluation of PKU (Phenylketonuria): Based on Comorbidities"
Grant ML
Invited speaker presentation at The Brain in PKU: Today and Tomorrow Symposium, Montreal, Quebec, Canada, May 11, 2018

"Psychological Assessments and Testing in Pediatric Care"
Grant ML
Medical Social Work CME Presentation, St Christopher’s Hospital for Children, Philadelphia, Pennsylvania, January 23, 2018

"Neurocognitive Outcomes of Pegvaliase Clinical Trial Study"
Grant ML
Presented at Neurocognitive Outcomes Clinical Development Advisory Board, Amsterdam, Netherlands, November 11, 2017

"Knowledge is Power: PKU, Brain and Behavior; Benefits of Maintaining Phe Control"
Grant ML
Maine Medical Center Metabolic Clinic and PKU Family Educational Event, Noblesboro, Maine, September, 22 2017

"Inborn Errors of Metabolism: Neurocognitive/Neurobehavioral Outcomes"
Grant ML
Presented at Texas Metabolic Summit, Austin, Texas, October 7, 2016

"Neurocognitive and Behavioral Assessments: When, Why, How"
Grant ML
Albany Medical Center Rare Disease Forum, Albany, New York, October 5, 2013

"Neuropsychology and Sickle Cell Disease"
Grant ML and Tarazi R
School District of Philadelphia (SDP) Professional Development Workshop, Philadelphia, Pennsylvania, November 6, 2012